kalata B2

conformation in first source

Networked: 2 relevant articles (0 outcomes, 0 trials/studies)

1.	Craik, David J: 2 articles (01/2015 - 09/2014)
2.	Fensterseifer, Isabel C M: 1 article (01/2015)
3.	Franco, Octavio L: 1 article (01/2015)
4.	Malik, Uru: 1 article (01/2015)
5.	Miranda, Paulo R R: 1 article (01/2015)
6.	Moreno, Susana E: 1 article (01/2015)
7.	Novaes, Natasha R F: 1 article (01/2015)
8.	Ravipati, Anjaneya S: 1 article (01/2015)
9.	Rodrigues, Elaine A: 1 article (01/2015)
10.	Silva, Osmar N: 1 article (01/2015)

1.	Neoplasms (Cancer) 09/05/2014 - "A novel set of analogues of kalata B1 (the prototypic cyclotide) and kalata B2 and cycloviolacin O2 were examined for their membrane-binding affinity and selectivity towards cancer cells. "
2.	Infections 01/01/2015 - "Here, cycloviolacin 2 (CyO2) and kalata B2 (KB2) were evaluated to determinate their anti-staphylococcal activities using a subcutaneous infection model. "